Similar results were observed in another study with circulating MDSC levels at 1.89% ± 0.75% in CRC patients and 0.54% ± 0.35% indicating a low percentage of CD33 HLA DR subset in peripheral blood [21]. This evidence concerns the gene CD33 and colorectal carcinoma.